Figures & data
Table 1 Open-source model use across drug-repurposing activities
Table 2 Drug-repurposing initiatives sponsored by public sector, private sector, and nonprofit organizations
Table 3 Models of collaboration, IP management, and human-capacity development employed by public and private sector-driven repurposing programs
Table 4 Examples of repurposed drugs for NTDs